Related Experiment Video
Updated: Aug 14, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
ALLHAT in perspective: implications to clinical practice and clinical trials
1Faculty of Medicine, Universiti Teknologi MARA, 20th Floor S&T Tower 1, Shah Alam 40450, Selangor, Malaysia.
The Medical Journal of Malaysia
|August 24, 2005
Summary
The ALLHAT study found no significant differences in primary outcomes between newer and older hypertension drugs. However, diuretics were recommended for first-line therapy due to secondary outcome benefits and cost-effectiveness.
Area of Science:
- Cardiovascular Medicine
- Clinical Trials
- Pharmacology
Background:
- The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was the largest randomized clinical trial for hypertension.
- Previous hypertension treatment guidelines lacked definitive evidence comparing newer agents to older, cost-effective diuretics.
Purpose of the Study:
- To compare the efficacy of amlodipine (calcium channel blocker) and lisinopril (ACE inhibitor) against chlorthalidone (diuretic) as initial treatments for hypertension.
Main Methods:
- Enrolled over 42,000 hypertensive patients.
- Followed participants for an average of 4.9 years.
- Assessed primary endpoints (cardiac events) and secondary endpoints (heart failure, stroke).
Main Results:
- No significant differences were observed in primary endpoints between amlodipine, lisinopril, and chlorthalidone.
- Chlorthalidone showed significant benefits in reducing heart failure compared to amlodipine and lisinopril.
- Secondary analyses indicated potential differences in stroke rates.
Conclusions:
- Investigators recommended diuretics as first-line therapy for hypertension based on secondary outcomes and economic factors.
- The ALLHAT study's findings and controversies have significantly influenced hypertension treatment guidelines, including JNC VII.
- Understanding ALLHAT is crucial for current clinical practice and future clinical trial design.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:27Ethical Issues
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...